Marzena Gawkowska-Suwinska
Overview
Explore the profile of Marzena Gawkowska-Suwinska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gawkowska-Suwinska M, Fijalkowski M, Bialas B, Szlag M, Kellas-Sleczka S, Nowicka E, et al.
J Contemp Brachytherapy
. 2017 Jan;
1(4):211-215.
PMID: 28050174
Purpose: The aim of the study was to analyze early effects and toxicity of salvage high dose rate brachytherapy for local recurrences of adenocarcinoma of the prostate after external beam...
2.
Wojcieszek P, Szlag M, Glowacki G, Cholewka A, Gawkowska-Suwinska M, Kellas-Sleczka S, et al.
Radiother Oncol
. 2016 May;
119(3):405-10.
PMID: 27165612
Background And Purpose: To evaluate high-dose-rate brachytherapy (HDR BT) as a salvage modality for locally recurrent prostate cancer after primary radiotherapy failure. Materials And Methods: Eighty-three prostate cancer patients, who...
3.
Boonstra P, Taylor J, Smolska-Ciszewska B, Behrendt K, Dworzecki T, Gawkowska-Suwinska M, et al.
Br J Radiol
. 2016 Feb;
89(1061):20150957.
PMID: 26903392
Objective: There is disagreement regarding the value of the α/β ratio for prostate cancer. Androgen deprivation therapy (ADT) may dominate the effects of dose fractionation on prostate-specific antigen (PSA) response...
4.
Butkiewicz D, Krzesniak M, Drosik A, Giglok M, Gdowicz-Klosok A, Kosarewicz A, et al.
Int J Cancer
. 2015 May;
137(10):2332-42.
PMID: 25975224
Certain common inherited variations in genes involved in tumor angiogenesis, progression and metastasis may contribute to cancer therapy outcome and prognosis by altering the gene expression and protein activity. In...
5.
Smolska-Ciszewska B, Miszczyk L, Bialas B, Fijalkowski M, Plewicki G, Gawkowska-Suwinska M, et al.
Radiat Oncol
. 2015 Apr;
10:60.
PMID: 25884489
Background: Clinical data that compare external-beam radiotherapy (EBRT) combined with high-dose-rate brachytherapy (HDR-BT) boost versus EBRT alone are scarce. The analysis of published studies suggest that biochemical relapse-free survival in...
6.
Gawkowska-Suwinska M, Blamek S, Heyda A, Boguszewicz L, Cichon A, Zarudzki L, et al.
Rep Pract Oncol Radiother
. 2014 Oct;
19(6):361-8.
PMID: 25337408
Aim: To evaluate the tolerability and toxicity of PCI in patients with NSCLC. Background: Prophylactic cranial irradiation (PCI) is a standard treatment for patients with small cell lung cancer. There...
7.
Behrendt K, Nowicka E, Gawkowska-Suwinska M, Plewicki G, Smolska-Ciszewska B, Giglok M, et al.
Rep Pract Oncol Radiother
. 2014 Sep;
19(5):337-42.
PMID: 25184059
Aim: To assess acute and late toxicity of hypofractionated radiotherapy, its efficacy and impact on quality of life in patients with low-risk prostate cancer. Materials And Methods: Since August 2006...
8.
Suwinski R, Klusek A, Tyszkiewicz T, Kowalska M, Szczesniak-Klusek B, Gawkowska-Suwinska M, et al.
PLoS One
. 2012 Aug;
7(7):e41379.
PMID: 22848476
Background: Several studies have shown the prognostic and predictive potential of molecular markers in combined therapy for lung cancer. Most of them referred, however, to operable early stage NSCLC. The...
9.
Butkiewicz D, Drosik A, Suwinski R, Krzesniak M, Rusin M, Kosarewicz A, et al.
Int J Cancer
. 2012 Apr;
131(7):E1100-8.
PMID: 22511383
Polymorphisms in DNA repair genes may modulate not only an individual DNA repair capacity, DNA damage levels and cancer risk but also clinical outcome after DNA damage-inducing anticancer therapy. In...
10.
Feldman-Stewart D, Capirci C, Brennenstuhl S, Tong C, Abacioglu U, Gawkowska-Suwinska M, et al.
Med Decis Making
. 2011 Jan;
31(5):754-66.
PMID: 21273630
Purpose: To describe decisional roles of patients with early-stage prostate cancer in 9 countries and to compare the information they rated important for decision making (DM). Method: A survey of...